<DOC>
	<DOCNO>NCT01061684</DOCNO>
	<brief_summary>The NAFLD Database 2 recruit least 650 new pediatric participant liver biopsy contemporaneous biosamples , also invite pediatric participant prior NAFLD Database TONIC trial ( 50 recent biopsy 150 without contemporaneous biopsy ) enroll NAFLD Pediatric Database 2 study . Combining new continue participant lead recruitment goal pediatric Database 2 850 pediatric participant enrollment period .</brief_summary>
	<brief_title>NAFLD Pediatric Database 2</brief_title>
	<detailed_description>All new pediatric participant liver biopsy within 120 day prior enrollment couple contemporaneous biosamples within 90 day prior enrollment 90 day 4-90 day biopsy . We estimate least 50 continue pediatric participant due standard care liver biopsy time enrollment pediatric Database 2 study , , result , also liver biopsy contemporaneous biosamples .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Continuing participant : Previously enrol NAFLD Database study TONIC trial Age least 2 year old 17 year consent process Willingness continue follow 4 year Ability willingness give write , inform parental consent child assent , per local IRB guideline , enrol pediatric Database 2 study New participant : Age least 2 year age old 17 year consent process Willingness follow 4 year Ability willingness give write , informed parent consent child assent enrol pediatric Database 2 study Minimal alcohol use history consistent NAFLD Having undergone liver biopsy obtain within 120 day enrollment Collection biosamples ( serum , plasma , DNA , , available , liver tissue ) within 90 day prior enrollment 090 day 490 day standard care liver biopsy Total parenteral nutrition 1 month within 6 month period baseline liver biopsy Short bowel syndrome History gastric jejunoileal bypass precede diagnosis NAFLD . Bariatric surgery perform follow enrollment exclusionary . Liver biopsy obtain bariatric surgery use enrollment associate surgical anesthetic acute change weight loss effort precede bariatric surgery History biliopancreatic diversion Evidence advance liver disease define ChildPughTurcotte score equal great 10 Evidence chronic hepatitis B mark presence HBsAg serum ( participant isolate antibody hepatitis B core antigen , antiHBc total , exclude ) Evidence chronic hepatitis C mark presence antiHCV HCV RNA serum Low alpha1antitrypsin level ZZ phenotype ( determine discretion investigator ) Wilson 's disease Known glycogen storage disease Known dysbetalipoproteinemia Known phenotypic hemochromatosis ( HII great 1.9 removal 4 g iron phlebotomy ) Prominent bile duct injury ( florid duct lesion periductal sclerosis ) bile duct paucity Chronic cholestasis Vascular lesion ( vasculitis , cardiac sclerosis , acute chronic BuddChiari , hepatoportal sclerosis , peliosis ) Iron overload great 3+ Zones confluent necrosis , infarction , massive submassive , panacinar necrosis Multiple epithelioid granulomas Congenital hepatic fibrosis Cystic fibrosis Polycystic liver disease Other metabolic congenital liver disease Evidence systemic infectious disease Known HIV positive Disseminated advance malignancy Concomitant severe underlie systemic illness opinion investigator would interfere completion followup Active drug use dependence , opinion study investigator , would interfere adherence study requirement Any condition , opinion investigator would impede compliance hinder completion study Inability parent provide inform consent child 8 year great give assent</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>fatty liver disease</keyword>
	<keyword>NASH</keyword>
	<keyword>NAFLD</keyword>
	<keyword>non-alcoholic steatohepatitis</keyword>
</DOC>